AUPO573697A0 - Diagnosis of endometrial cancer - Google Patents

Diagnosis of endometrial cancer

Info

Publication number
AUPO573697A0
AUPO573697A0 AUPO5736A AUPO573697A AUPO573697A0 AU PO573697 A0 AUPO573697 A0 AU PO573697A0 AU PO5736 A AUPO5736 A AU PO5736A AU PO573697 A AUPO573697 A AU PO573697A AU PO573697 A0 AUPO573697 A0 AU PO573697A0
Authority
AU
Australia
Prior art keywords
endometrial cancer
diagnosis
matrix metalloproteinase
assaying
qualitative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO5736A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Prince Henrys Institute of Medical Research
Original Assignee
University of Melbourne
Prince Henrys Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Melbourne, Prince Henrys Institute of Medical Research filed Critical University of Melbourne
Priority to AUPO5736A priority Critical patent/AUPO573697A0/en
Publication of AUPO573697A0 publication Critical patent/AUPO573697A0/en
Priority to DE69835010T priority patent/DE69835010T2/de
Priority to KR1019997009429A priority patent/KR20010006344A/ko
Priority to NZ337868A priority patent/NZ337868A/en
Priority to CN98805312A priority patent/CN1257550A/zh
Priority to JP54453698A priority patent/JP4183757B2/ja
Priority to AU63859/98A priority patent/AU728286B2/en
Priority to ES98909221T priority patent/ES2268767T3/es
Priority to US09/381,454 priority patent/US6607894B1/en
Priority to ZA982403A priority patent/ZA982403B/xx
Priority to CA2284099A priority patent/CA2284099C/en
Priority to PCT/AU1998/000189 priority patent/WO1998042865A1/en
Priority to AT98909221T priority patent/ATE331039T1/de
Priority to MYPI98001218A priority patent/MY119567A/en
Priority to EP98909221A priority patent/EP0979304B1/en
Priority to JP2007001867A priority patent/JP2007202556A/ja
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AUPO5736A 1997-03-20 1997-03-20 Diagnosis of endometrial cancer Abandoned AUPO573697A0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
AUPO5736A AUPO573697A0 (en) 1997-03-20 1997-03-20 Diagnosis of endometrial cancer
EP98909221A EP0979304B1 (en) 1997-03-20 1998-03-20 Detection of endometrial cancer
AU63859/98A AU728286B2 (en) 1997-03-20 1998-03-20 Detection of endometrial cancer
US09/381,454 US6607894B1 (en) 1997-03-20 1998-03-20 Matrix metalloproteinase levels as indicators of endometrial cancer
NZ337868A NZ337868A (en) 1997-03-20 1998-03-20 Detection of endometrial cancer using a matrix metalloprotease
CN98805312A CN1257550A (zh) 1997-03-20 1998-03-20 子宫内膜癌的检测
JP54453698A JP4183757B2 (ja) 1997-03-20 1998-03-20 子宮内膜ガンの検出
DE69835010T DE69835010T2 (de) 1997-03-20 1998-03-20 Feststellung von endometriumkrebs
ES98909221T ES2268767T3 (es) 1997-03-20 1998-03-20 Deteccion de cancer de endometrio.
KR1019997009429A KR20010006344A (ko) 1997-03-20 1998-03-20 자궁내막암의 검출 방법
ZA982403A ZA982403B (en) 1997-03-20 1998-03-20 Detection of endometrial cancer
CA2284099A CA2284099C (en) 1997-03-20 1998-03-20 Detection of endometrial cancer
PCT/AU1998/000189 WO1998042865A1 (en) 1997-03-20 1998-03-20 Detection of endometrial cancer
AT98909221T ATE331039T1 (de) 1997-03-20 1998-03-20 Feststellung von endometriumkrebs
MYPI98001218A MY119567A (en) 1997-03-20 1998-03-20 Matrix metalloproteinase levels as indicators of endometrial cancer
JP2007001867A JP2007202556A (ja) 1997-03-20 2007-01-09 子宮内膜ガンの検出

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO5736A AUPO573697A0 (en) 1997-03-20 1997-03-20 Diagnosis of endometrial cancer

Publications (1)

Publication Number Publication Date
AUPO573697A0 true AUPO573697A0 (en) 1997-04-10

Family

ID=3800039

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO5736A Abandoned AUPO573697A0 (en) 1997-03-20 1997-03-20 Diagnosis of endometrial cancer

Country Status (14)

Country Link
US (1) US6607894B1 (cg-RX-API-DMAC10.html)
EP (1) EP0979304B1 (cg-RX-API-DMAC10.html)
JP (2) JP4183757B2 (cg-RX-API-DMAC10.html)
KR (1) KR20010006344A (cg-RX-API-DMAC10.html)
CN (1) CN1257550A (cg-RX-API-DMAC10.html)
AT (1) ATE331039T1 (cg-RX-API-DMAC10.html)
AU (1) AUPO573697A0 (cg-RX-API-DMAC10.html)
CA (1) CA2284099C (cg-RX-API-DMAC10.html)
DE (1) DE69835010T2 (cg-RX-API-DMAC10.html)
ES (1) ES2268767T3 (cg-RX-API-DMAC10.html)
MY (1) MY119567A (cg-RX-API-DMAC10.html)
NZ (1) NZ337868A (cg-RX-API-DMAC10.html)
WO (1) WO1998042865A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA982403B (cg-RX-API-DMAC10.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045147A1 (en) * 1998-03-05 1999-09-10 Diadexus Llc A novel method of detecting and monitoring endometrial and uterine cancers
AUPQ219799A0 (en) 1999-08-13 1999-09-02 R. Lurie Pty Ltd Apparatus for obtaining potological samples
US7094754B2 (en) 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
DE10217677A1 (de) 2002-04-19 2003-11-06 Bayer Ag Verwendung von Aufhellern zur Herstellung von Streichmassen
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
EP1782068B1 (en) * 2004-07-23 2010-04-07 Centre de Recherche Public de la Santé Monitoring heart failure
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
WO2006086730A2 (en) * 2005-02-09 2006-08-17 Genentech, Inc. Inhibiting her2 shedding with matrix metalloprotease antagonists
US7504225B2 (en) * 2005-05-12 2009-03-17 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
RU2304782C1 (ru) * 2005-12-28 2007-08-20 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Способ прогнозирования рецидива эндометриоидной кисты яичника
EP2205642B1 (en) 2007-11-02 2016-01-27 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
DK2419736T3 (da) * 2009-04-16 2014-04-22 Momenta Pharmaceuticals Inc Fremgangsmåder til vurdering af aktivitet af en polysaccharidsammensætning
CN105132529A (zh) * 2009-07-24 2015-12-09 吉第克生物技术有限公司 子宫内膜癌的标记物
BR112012026542A2 (pt) 2010-04-16 2016-07-12 Momenta Pharmaceuticals Inc abordagem seletiva de tecido
RU2430371C1 (ru) * 2010-04-26 2011-09-27 Учреждение Российской академии наук Институт ядерной физики им. Г.И. Будкера Сибирского отделения РАН (ИЯФ СО РАН) Способ дифференциальной диагностики и прогноза миомы и рака эндометрия
AU2011268470B2 (en) 2010-06-17 2017-02-02 Momenta Pharmaceuticals, Inc. Methods and compositions for promoting hair growth
CA2838053A1 (en) * 2011-06-03 2012-12-06 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
CN107389936A (zh) * 2011-09-22 2017-11-24 斯隆-凯特林纪念癌症中心 检测卵巢癌
HRP20181726T1 (hr) * 2012-01-31 2018-12-28 SPEISER, Paul Neinvazivno dijagnosticiranje raka
US10016449B2 (en) 2013-05-28 2018-07-10 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
AU2015283811A1 (en) * 2014-07-02 2017-02-09 Bionomics Limited Predictive biomarkers
CA2975737A1 (en) * 2015-02-06 2016-08-11 Quest Diagnostics Investments Llc Compositions and methods for determining endometrial cancer prognosis
PT3452829T (pt) * 2016-05-04 2024-03-22 Fundacio Hospital Univ Vall Dhebron Institut De Recerca Perm como marcador de cancro endometrial
IN202021002695A (cg-RX-API-DMAC10.html) 2020-01-21 2021-07-23
CN112961921B (zh) * 2021-03-26 2022-07-01 中国医学科学院北京协和医院 一种用于判断早期子宫内膜癌预后的制剂及复发风险模型

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
WO1994005807A1 (en) * 1992-08-28 1994-03-17 Dickson Robert B Matrix-degrading metalloproteinase
JPH09503901A (ja) * 1992-11-16 1997-04-22 キャンサー リサーチ ファンド オブ コントラ コスタ 広範な新生物特異性を有するペプチドおよびアンチセンスペプチド

Also Published As

Publication number Publication date
MY119567A (en) 2005-06-30
WO1998042865A1 (en) 1998-10-01
EP0979304A4 (en) 2003-06-11
ES2268767T3 (es) 2007-03-16
DE69835010D1 (de) 2006-08-03
EP0979304B1 (en) 2006-06-21
JP2002501613A (ja) 2002-01-15
JP4183757B2 (ja) 2008-11-19
ATE331039T1 (de) 2006-07-15
DE69835010T2 (de) 2007-06-06
US6607894B1 (en) 2003-08-19
NZ337868A (en) 2002-05-31
CN1257550A (zh) 2000-06-21
CA2284099A1 (en) 1998-10-01
KR20010006344A (ko) 2001-01-26
EP0979304A1 (en) 2000-02-16
JP2007202556A (ja) 2007-08-16
ZA982403B (en) 1998-10-21
CA2284099C (en) 2010-04-27

Similar Documents

Publication Publication Date Title
ZA982403B (en) Detection of endometrial cancer
AU5212199A (en) Methods and kits for diagnosing and determination of the predisposition of diseases
AU4157696A (en) Quantitative method for early detection of mutant alleles and diagnostic kits for carrying out the method
WO2000023614A8 (en) Method for monitoring proteasome inhibitor drug action
IL114564A (en) Method for the sensitive detection of nucleic acids
AU1674400A (en) Kidney disease detection and treatment
WO2001027857A3 (en) Methods for generating databases and databases for identifying polymorphic genetic markers
AU2144000A (en) Complexity management and analysis of genomic dna
DE69633940D1 (de) Verfahren zur isolierung von zellen
ZA979071B (en) Detecting genetic predisposition to sight-threatening diabetic retinopathy
DE3750093D1 (de) Test zur Feststellung der Empfänglichkeit für DNS-assoziierte Krankheiten.
IL81695A (en) Quantitative determination of the degree of amplification of genes and/or corresponding messenger rna and reagent kit for performing the determination
CA2269664A1 (en) Diagnostic assay for breast cancer susceptibility
AU2304697A (en) Diagnostic method and apparatus
GB9604305D0 (en) Diagnostic method and apparatus
AU2904197A (en) Diagnostic method and apparatus based on polymorphism in an IL-6 gene
AU5218599A (en) Method and system for identifying at risk patients diagnosed with diabetes
EP0315058A3 (en) Method for self-performing enzyme kinetics
BR0007056A (pt) Enzima mutante produtora de nucleosìdeo-5' -fosfato, métodos para a produção de uma enzima mutante produtora de nucleosìdeo-5' -fosfato, de um inibidor para uma enzima fosfatase ou de transfosforilação e de um nucleosìdeo-5' -fosfato, cristais de uma enzima, de fosfatase ácida e de complexo de fosfatase ácida, gene, dna recombinante, e, microorganismo
AU4407285A (en) Methods and apparatus for carrying out clinical, chemical and biological testing
AR014969A1 (es) Formulacion que contienen por lo menos una proteina tardia (proteina l) de uno o mas papilomavirus y/o por lo menos una proteina temprana (proteina e) deuno o mas papilomavirus, procedimiento para la preparacion de la formulacion mencionada asi como su utilizacion para la manufactura de un medicamen
AU5801196A (en) Relaxin diagnostic assays and kits, and methods and uses thereof
UA10262A (uk) Спосіб ультразвукової діагностики стану судин головного мозку
UA10260A (uk) Спосіб діагностики невиношування вагітності у першому триместрі
UA20025A (uk) Спосіб прогhозуваhhя затримки розвитку плода